PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 38 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,519 | -40.9% | 37,060 | -28.8% | 0.00% | – |
| Q2 2023 | $104,080 | +956.5% | 52,040 | +1009.4% | 0.00% | – |
| Q1 2023 | $9,851 | +5906.7% | 4,691 | +3809.2% | 0.00% | – |
| Q4 2022 | $164 | -98.5% | 120 | -98.9% | 0.00% | – |
| Q3 2022 | $11,000 | – | 11,118 | +9165.0% | 0.00% | – |
| Q2 2022 | $0 | – | 120 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 120 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 120 | -94.8% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 2,314 | +20.2% | 0.00% | – |
| Q2 2021 | $3,000 | -70.0% | 1,925 | -12.3% | 0.00% | – |
| Q1 2021 | $10,000 | +100.0% | 2,195 | +83.4% | 0.00% | – |
| Q4 2020 | $5,000 | -70.6% | 1,197 | -73.5% | 0.00% | – |
| Q3 2020 | $17,000 | +21.4% | 4,512 | +23.5% | 0.00% | – |
| Q2 2020 | $14,000 | – | 3,653 | +1940.8% | 0.00% | – |
| Q1 2020 | $0 | – | 179 | +258.0% | 0.00% | – |
| Q4 2019 | $0 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 2,470,332 | $8,967,000 | 6.83% |
| Psagot Value Holdings Ltd. | 470,255 | $1,707,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 212,591 | $772,000 | 0.02% |
| UBS OCONNOR LLC | 150,000 | $544,000,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 10,042 | $36,000 | 0.01% |
| Renaissance Technologies | 488,634 | $1,774,000 | 0.00% |
| Squarepoint Ops LLC | 22,068 | $80,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 222 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 50,280 | $183,000 | 0.00% |